Alantolactone from Inula racemosa improved cognitive impairment in P. gingivalis-infected rats by reducing neuroinflammation, Aβ levels, and oxidative stress via Nrf2/HO-1 pathway activation.
COVID-19 has impacted over 190 million people worldwide, leading to major global crises. Researchers believe simultaneously boosting patient immunity while targeting viral proteins may reduce the severity of the infection, due to the virus's rapidly mutating genome.